Global Spasmodic Dysphonia Treatment Market, By Type (Adductor Spasmodic Dysphonia, Abductor Spasmodic Dysphonia, Mixed Spasmodic Dysphonia), Treatment (Surgery, Therapy), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2030.
Spasmodic Dysphonia Treatment Market Analysis and Size
The occurrence and prevalence of SD is very rare. There may be between 10,000 to 30,000 affected individuals in the U.S. as recorded by the National Spasmodic Dysphonia Association. Increasing adoption of generic drugs which may cause hindrance in nervous system, lack of awareness about abnormal sound produced while speaking, rising stressful conditions continuing with daily routine are the factors estimated to boost the growth of the spasmodic dysphonia treatment market.
Data Bridge Market Research analyses a growth rate in the spasmodic dysphonia treatment market in the forecast period 2023-2030. The expected CAGR of spasmodic dysphonia treatment market is tend to be around 3% in the mentioned forecast period. The market was valued at USD 13.41 billion in 2022, and it would grow upto USD 17 billion by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Spasmodic Dysphonia Treatment Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023-2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Adductor Spasmodic Dysphonia, Abductor Spasmodic Dysphonia, Mixed Spasmodic Dysphonia), Treatment (Surgery, Therapy), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
National Spasmodic Dysphonia Association (U.S.), Dystonia Medical Research Foundation (U.S.), DAIICHI SANKYO COMPANY, LIMITED (Japan), Fresenius Kabi AG (Germany), Shanghai Fosun Pharmaceutical（Group）Co., Ltd.(China)
|
|
Market Opportunities
|
|
Market Definition
Spasmodic dysphonia, also called laryngeal dystonia, is a disorder affecting the voice muscles, in the larynx causing the break in voice during speaking, making the sound tight, strained or breathy. In many cases, spasm may occur in every word. People with spasmodic dysphonia may have vocal tremor, shaking of the larynx and vocal folds that is causing the voice to tremble.
Spasmodic Dysphonia Treatment Market Dynamics
Drivers
- Availability of Advanced Treatment Procedures
With each passing decade, varied treatment methods are being available that would help the patients' faster recovery. Treatment advancements in terms of several therapies such as voice therapy, singing therapy, swallow therapy and different surgical options are on the rise. Thus, it acts as a major driver in the market growth.
- Increase in the number of research and development activities
The market's growth is fuelled by the rise in the number of research and development activities. This will provide beneficial opportunities for the market. To encourage researchers and pharmaceutical companies to develop novel medicines, the government is funding research and development (R&D) initiatives.
Opportunities
- Increased Demands of Specialized and Personalized Diagnostic Methods
There is no specific diagnostic procedures that are available for this consition. Diagnosis is based on the patient's description of the symptoms present, the sound of the voice, and the observation of the vocal folds during speech by laryngologist and speech-language pathologist.
- Increasing Demand for Retail Pharmacies
The use of several drugs for spasmodic dysphonia delivered through retail pharmacies and surge in the number of retail pharmacies in highly developed countries create opportunities for market growth. In addition to this, patients prefer retail pharmacies for purchasing drugs, as these are easily available.
Restraints/Challenges
- Lack of skilled professionals
The lack of trained healthcare professionals who cannot treat the patients with appropriate treatments could limit the growth of the global spasmodic dysphonia treatment market during a forecast period.
- High Cost For Drug Development
The current treatment options for spasmodic dysphonia treatment are limited to therapies and surgeries, and numerous pharmaceutical companies are presently focusing on developing non-antibiotic alternatives. Developing a new class of drugs will offer many growth opportunities for key players, but it will also essentially require major investments in R&D activities of novel therapies. The significantly high investment requirements may act as an obstacle to market growth.
This spasmodic dysphonia treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the spasmodic dysphonia treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Spasmodic Dysphonia Treatment Market Scope
The spasmodic dysphonia treatment market is segmented on the basis of type, treatment, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Adductor Spasmodic Dysphonia
- Abductor Spasmodic Dysphonia,
- Mixed Spasmodic Dysphonia
Treatment
- Therapy
- Direct Microlaryngoscopy
- Pulse Dye Laser
- Botox Injections/Injection Laryngoplasty
- Minimally Invasive Approaches
- Surgery
- Voice therapy
- Laryngeal desensitization
- Respiratory re-training
- Swallow therapy
- Singing therapy
- Voice lessons
- Accent modification
Type
- Drugs
- Preventive Vaccines
- Oxygen Therapy
Route of Administration
- Oral
- Parenteral
- Others
End User
- Hospitals
- Homecare
- Specialty Clinics
- Others
Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Spasmodic Dysphonia Treatment Market Regional Analysis/Insights
The spasmodic dysphonia treatment market is analyzed and market size insights and trends are provided by type, treatment, distribution channel and end-user as referenced above.
The major countries covered in the spasmodic dysphonia treatment market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America has been witnessing a positive growth for spasmodic dysphonia treatment market throughout the forecasted period due to the increasing demand of disease specific treatment and rise in adoption of newer technologies.
Asia-Pacific dominates the market due to increased prevalence of patient awareness and refined healthcare expenditures.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Spasmodic Dysphonia Treatment Market Share Analysis
The spasmodic dysphonia treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to spasmodic dysphonia treatment market.
Key players operating in the spasmodic dysphonia treatment market include:
- National Spasmodic Dysphonia Association (U.S.)
- Dystonia Medical Research Foundation (U.S.)
- DAIICHI SANKYO COMPANY, LIMITED (Japan)
- Fresenius Kabi AG (Germany)
- Shanghai Fosun Pharmaceutical（Group）Co., Ltd.(China)
SKU-